DOT-C: a cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community …
A Radley, J Tait, JF Dillon - International Journal of Drug Policy, 2017 - Elsevier
Background Direct-acting antiviral therapy (DAAs) for hepatitis C infection (HCV) have a
much smaller burden of treatment than interferon-based regimes, require less monitoring …
much smaller burden of treatment than interferon-based regimes, require less monitoring …
Primary care and hepatology Provider–Perceived barriers to and facilitators of hepatitis C treatment Candidacy and adherence
SS Rogal, R McCarthy, A Reid, KL Rodriguez… - Digestive diseases and …, 2017 - Springer
Background Provider perceptions regarding barriers to and facilitators of hepatitis C (HCV)
treatment initiation and adherence have not been fully evaluated in the interferon-free …
treatment initiation and adherence have not been fully evaluated in the interferon-free …
[HTML][HTML] A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol …
MC Herink, A Seaman, G Leichtling, JE Larsen… - Addiction Science & …, 2023 - Springer
Abstract Background Hepatitis C virus (HCV) transmission is primarily driven by injection
drug use, and acute HCV infection rates are increased in rural communities with substantial …
drug use, and acute HCV infection rates are increased in rural communities with substantial …
A quasi-experimental evaluation of dried blood spot testing through community pharmacies in the Tayside region of Scotland
A Radley, K Melville, J Tait, B Stephens… - Frontline …, 2017 - fg.bmj.com
Objective Comparison of uptake of dried blood spot testing (DBST) for hepatitis C virus
(HCV) infection between community pharmacies and established services. Design …
(HCV) infection between community pharmacies and established services. Design …
[HTML][HTML] Re-evaluation of chronic hepatitis B and hepatitis C patients lost to follow-up: results of the Northern Holland hepatitis retrieval project
N Beekmans, M Klemt-Kropp - Hepatology, Medicine and Policy, 2018 - Springer
Background Many persons infected with Hepatitis B virus (HBV) and Hepatitis C virus (HCV)
in the past are now lost to follow-up. The aim of the Northern Holland Hepatitis Retrieval …
in the past are now lost to follow-up. The aim of the Northern Holland Hepatitis Retrieval …
Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?
Background Multiple barriers for accessing hepatitis C virus (HCV) treatment were identified
during the interferon-based (IFN) treatment era for people who inject drugs (PWID). Whether …
during the interferon-based (IFN) treatment era for people who inject drugs (PWID). Whether …
[HTML][HTML] Integrating care for patients with chronic liver disease and mental health and substance use disorders
Integrating Care for Patients With Chronic Liver Disease and Mental Health and Substance
Use Disorders - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Use Disorders - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Belgian experience with direct acting antivirals in people who inject drugs
R Bielen, C Moreno, H Van Vlierberghe… - Drug and alcohol …, 2017 - Elsevier
Background and aim Hepatitis C viral infection (HCV) has become a curable disease due to
the development of direct acting antivirals (DAA). The WHO has set a target to eliminate …
the development of direct acting antivirals (DAA). The WHO has set a target to eliminate …
[HTML][HTML] Hepatitis C virus prevention and care for drug injectors: the French approach
JM Delile, V de Ledinghen, M Jauffret-Roustide… - … , medicine and policy, 2018 - Springer
After France removed hepatitis C treatment reimbursement restrictions on 25 May 2016, an
expert report presented recommendations, which focused on vulnerable groups including …
expert report presented recommendations, which focused on vulnerable groups including …
Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study …
Introduction Hepatitis C virus (HCV) infection affects 0.7% of the general population, and up
to 40% of people prescribed opioid substitution therapy (OST) in Scotland. In conventional …
to 40% of people prescribed opioid substitution therapy (OST) in Scotland. In conventional …